Search results
Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve
Benzinga via Yahoo Finance· 2 years agoLast week, Collegium Pharmaceutical Inc (NASDAQ: COLL) reported Q2 results—the first full quarter...
Last week, Collegium Pharmaceutical Inc (NASDAQ: COLL) reported Q2 results—the first full quarter...